SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,592.45 -318.56
( -0.39%)

Global Indices

Nasdaq

52,431.30 -76.19
(-0.15%)

Dow Jones

7,621.14 -19.24
(-0.25%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,906.25 43.16
(0.40%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Rajnish Wellness Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541601

INE685Z01033

1.0145172

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

39.6

EPS(TTM)

Face Value()

Div & Yield %

Back

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit

Aug 22,2026

Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

81,592.45 -318.56 ( -0.39%)

52,431.30 -76.19 (-0.15%)

7,621.14 -19.24 (-0.25%)

61,109.24 289.88 (0.48%)

10,906.25 43.16 (0.40%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)